Dr. Matthew S. Hale, MD

Dr. Hale practices at Southeast Georgia Health System-Camden Campus in Saint Marys, Georgia, part of Southeast Georgia Health System.

Dr. Hale's NPI, 1558411397, was assigned on January 12, 2007. Dr. Hale graduated from Medical University of South Carolina (MUSC) in 2006. Dr. Hale holds Florida license ME103060.

Dr. Hale's primary practice is Southeast Georgia Health System-Camden Campus, at 2000 Dan Proctor Drive, Saint Marys, GA 31558 in Camden County. The practice phone is (912) 576-6401.

Dr. Hale's primary practice is Southeast Georgia Health System-Camden Campus in Saint Marys, Georgia, part of Southeast Georgia Health System. Dr. Hale is also affiliated with UF Health Jacksonville. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Dr. Hale to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hale practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Hale's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Hale is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Hale's licenses on file in 2 states: Florida and Georgia.

CMS data shows 539 Medicare services from Dr. Hale across 5 procedure codes in 2024, for 471 Medicare patients. Medicare paid $53,909 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 471 Medicare patients who saw Dr. Hale in 2024. The largest group is 75 to 84, with 177 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hale's median patient age at 70, with 60% women.

In 2024, Dr. Hale wrote 610 Medicare Part D claims for 332 patients. 95% of them were for generic drugs. CMS names the drug for 439 of them, across 16 drugs with 11 or more claims each, at $2,941 in total drug cost. In 2023, CMS named 302 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hale for performance year 2024, reported as part of a group. Dr. Hale accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Hale, published from 2014 to 2023. 2014 was the busiest year, with 3. Dr. Hale has published most often in Am J Emerg Med. Dr. Hale's most frequent co-authors are Abubakr Akhtar Bajwa, MD, Kelly Rae Gray-Eurom, MD and Faheem Wagid Guirgis, MD.

CMS Open Payments shows 48 general payments to Dr. Hale from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $938.

Dr. Hale graduated from Medical University of South Carolina (MUSC) in 2006.

Dr. Hale is in network with 5 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross and Blue Shield of Kansas City. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.